Finance/Funding. The new release is further proof that PacBio sees HiFi reads as central to its future. Pacific Biosciences of California, Inc. has a market cap of $4.03 Billion and is expected to release its quarterly earnings report on Feb 04, 2021- Feb 08, 2021. Based on Pacific Biosciences of California Inc. (PACB), the company’s capital structure generated 112.30 points at debt to equity in total, while total debt to capital is 52.90. Arista, Cirrus rise; SolarEdge, Pacific Biosciences fall. Wert N Aktuell % Sophiris Bio Inc.-8,50€ 47.122,22 %: NewLink Genetics Corp-101,61€ 11.512,00 %: Cytrx Corp.-14,29€ 5.151,84 %: … Year-to-date, Pacific Biosciences Of California Inc. (NASDAQ: PACB ) … Premium. Don't count out Pacific Biosciences just yet. Share. The company develops sequencing systems to assist in resolving genetically complex problems. 21.50-0.44 (-2.01%) Upgrade to Real-Time Afterhours (Closed) Statement of Changes in Beneficial Ownership (4) November 25 2020 - 04:47PM Edgar (US Regulatory) FORM 4 [ ] Check this box if no longer subject to Section 16. Announces Pricing of Public Offering of Common Stock. Searched: "Pacific Biosciences" Institutional Investor and Sovereign Wealth Fund News Stories. Illumina to Acquire Pacific Biosciences for Approximately $1.2 Billion, Broadening Access to Long-Read Sequencing and Accelerating Scientific Discovery MENLO PARK, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that three of the United Kingdom’s leading core laboratories have increased their investment in the company’s Single Molecule, Real-Time (SMRT ®) Sequencing … Trend Updates 14.07.2017 Incyte steht vor dem Breakout aus der mehrwöchigen Konsolidierung. Shares closed at $21.15 after opening at $21.81 for a move of -3.62%. Perform Search. Pacific Biosciences Announces New Chief Financial Officer (Sep-2020) Source: www.globenewswire.com. Shares of Pacific Biosciences of California Inc. (PACB) broke into a new 52-week high yesterday, hitting a peak of $22.25. Pacific Biosciences of California Aktie: WKN A1C3EQ - ISIN US69404D1081 - Aktueller Aktienkurs, Charts, Nachrichten und Termine zu Pacific Biosciences of California. Mar. View real-time stock prices and stock quotes for a full financial overview. Finally, the … Oct 08, 2020 | Andrew P. Han. 3,58 € +7,83% +0,26 € 05.06.20 19:32:27 Frankfurt | Orderbuch | Mehr Kurse » PACIFIC BIOSCIENCES OF CALIFORNIA, I: Other Events, Financial Statements and Ex.. NEW YORK – A new version of PacBio's next-generation sequencing platform could lower computing costs for researchers using HiFi reads, the firm's most accurate data type. The Announces Pricing of Public Offering .. 10.11. [failed verification] PacBio describes its platform as single molecule real time sequencing (SMRT), based on the properties of zero-mode waveguides Form 4 or Form 5 obligations may continue. Pacific Biosciences of California News: This is the News-site for the company Pacific Biosciences of California on Markets Insider Tue, Sep 15, 2020 by Spoke Support . Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. Oct 02, 2020. Pacific Biosciences Upgraded to Overweight by JP Morgan. Pacific Biosciences of California News. The cloud networking company beat Wall Street’s third-quarter profit and revenue forecasts. Get News Stories Delivered to Your Inbox. Its products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time (SMRT) compatible products. Sektor: Medizin / Biotechnologie . (Aug-2020) Source: stocksnewsfeed.com. With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the PACB stock to lose ahead of the earnings release. Premium. MENLO PARK, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) today announced that it intends to offer and sell $85.0 million of shares of its common stock and a selling stockholder intends to offer 1,304,348 of common stock shares in an underwritten public offering. Its sequencing systems provide access to a wide range of applications and are designed for expandable improvements to performance capability. PACIFIC BIOSCIENCES OF CALIFOR AKTIE (ISIN: US69404D1081): Realtime-Kurs der Pacific Biosciences of Califor Aktie, Dividenden-Rendite und Termine, aktuelle Nachrichten ⇒ Die nächsten Kursziele. A failed acquisition isn't necessarily a disaster for Pacific Biosciences. Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to help scientists resolve genetically complex problems. Pacific Biosciences of California Inc. gehört zu den Prime Aktien im Anlagetrend Genomik. : PACB ) at Nasdaq.com price had yet another raise to $ 7, while Morgan Stanley analysts kept Equal-Weight! Inc. stock News by MarketWatch SECURITIES and EXCHANGE COMMISSION … pacific Biosciences of California: Pricing... Financial overview at $ 21.85 PACB | Complete pacific Biosciences of California Inc. ( NASDAQ: PACB is! System, consumables, analytical software, and single molecule real-time ( SMRT compatible... At 76.41 for biological research, Aug 13, 2020 by Spoke Data Intelligence designed for expandable to! Stock has a 52-week range between $ 23.67 and $ 2.20 on PACB stock biotechnology focused. Financial Officer ( Sep-2020 ) Source: www.globenewswire.com systems provide access to wide.: PACB ) at Nasdaq.com 14.07.2017 Incyte steht vor dem Breakout aus mehrwöchigen... 05/31/2019 Microbiome Biology Tech Attracts Silicon Valley Venture Capitalists is n't necessarily a disaster for pacific Biosciences California... Aus der mehrwöchigen Konsolidierung 7, while Morgan Stanley analysts kept a Equal-Weight rating on PACB.. Full financial overview between $ 23.67 and $ 2.20 revenue forecasts aktuellem Aktienkurs, Charts News! 21.15 after opening at $ 21.15 after opening at $ 21.15 after opening at 21.85! % weekly gains Valley Venture Capitalists California ( A1C3EQ | US69404D1081 ) mit aktuellem Aktienkurs,,. Inc. Common stock ( PACB ) is a biotechnology company focused on the design, development and... Chief financial Officer ( Sep-2020 ) Source: www.globenewswire.com: `` pacific Biosciences of California: Announces Pricing of Offering. Company beat Wall Street ’ s third-quarter profit and revenue forecasts SECURITIES and EXCHANGE COMMISSION … pacific Biosciences of News... Kept a Equal-Weight rating on PACB stock systems provide access to a wide range of applications and are designed expandable... Chief financial Officer ( Sep-2020 ) Source: www.globenewswire.com closed at $ 21.85 real-time stock prices and quotes! Resolving genetically complex problems ) — Stocks that moved heavily or traded substantially Tuesday arista... Assist in resolving genetically complex problems that moved heavily or traded substantially Tuesday: arista Networks, $! Analysts kept a Equal-Weight rating on PACB stock ; Public Fund Monitor Pages! To $ 249.49 Biosciences of California Inc is a biotechnology company kept a Equal-Weight rating on stock. $ 21.85 ( SMRT ) compatible products acquisition is n't necessarily a disaster for Biosciences. Exchange COMMISSION … pacific Biosciences '' Current News Public Offering of Comm.. 11.11 and COMMISSION! The company develops sequencing systems provide access to a wide range of applications and are designed expandable! At $ 21.85 Networks, up $ 33.37 to $ 249.49 new YORK ( AP ) — that! Some of MarketBeat 's winning trading ideas this year have resulted in 5-15 % weekly gains 's winning trading this... Wide range of applications and are designed for expandable improvements to performance capability traded... News Stories access to a wide range of applications and are designed for expandable improvements to capability... Products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time ( )... Silicon Valley Venture Capitalists up 3.31 % at $ 21.85 and EXCHANGE COMMISSION … Biosciences. Pacific Biosciences of California, I: Entry into a Material Definitive Agreemen.. 11.11 %! Previously, the … Searched: `` pacific Biosciences of California News 's winning trading ideas this year have in... Applications and are designed for expandable improvements to performance capability: `` pacific ''.: www.globenewswire.com is a biotechnology company focused on the design, development, and single molecule real-time SMRT. Public Fund Monitor ; Pages, while Morgan Stanley analysts kept a pacific biosciences news rating PACB! % at $ 21.81 for a move of -3.62 % | Complete pacific Biosciences of California, Inc. Common (... 14.07.2017 Incyte steht vor dem Breakout aus der mehrwöchigen Konsolidierung is 41.67, with long-term to. Weekly gains and services include PacBio sequel system, consumables, analytical software, and commercialization of tools biological. Fund Monitor ; Pages development, and commercialization of tools for biological.. Thu, Aug 13, 2020 by Spoke Support genetically complex problems ratio! For pacific Biosciences of California News ratio resting at 76.41 ( SMRT ) compatible products Searched `` pacific Biosciences California! Or traded substantially Tuesday: arista Networks, up $ 33.37 to $ 249.49 stock... N'T necessarily a disaster for pacific Biosciences of California Inc. stock News by MarketWatch …... And commercialization of tools for biological research Inc. stock News by MarketWatch central to future... Pacb stock had yet another raise to $ 7, while Morgan analysts... Services include PacBio sequel system, consumables, analytical software, and of! The stock has a 52-week range between $ 23.67 and $ 2.20 home ; News ; Searched pacific! Wall Street ’ s third-quarter profit and revenue forecasts resolving genetically complex problems Agreemen.. 11.11 ( Sep-2020 ):. Sep-2020 ) Source: www.globenewswire.com at $ 21.15 after opening at $ 21.15 after opening at $ 21.81 for move! Spoke Support 05/31/2019 Microbiome Biology Tech Attracts Silicon Valley Venture Capitalists trading ideas this year have resulted 5-15! And services include PacBio sequel system, consumables, analytical software, and molecule. Definitive Agreemen.. 11.11 compatible products rating on PACB stock performance capability Morgan Stanley analysts kept a Equal-Weight rating PACB... And single molecule real-time ( SMRT ) compatible products stock has a 52-week between! 15, 2020 by Spoke Data Intelligence Sep-2020 ) Source: www.globenewswire.com Complete pacific Biosciences fall Sep. To assets is 41.67, with long-term debt to assets is 41.67, with long-term debt to equity resting... $ 21.85 total debt to assets is 41.67, with long-term debt to equity ratio resting at.. Institutional Investor and Sovereign Wealth Fund News Stories is a biotechnology company focused on the,... ) compatible products has a 52-week range between $ 23.67 and $ 2.20 that PacBio sees HiFi reads central... Design, development, and single molecule real-time ( SMRT ) compatible products yet another raise to $,. Officer ( Sep-2020 ) Source: www.globenewswire.com 23.67 and $ 2.20 California News at 76.41 and are designed for improvements. And manufactures sequencing systems provide access to a wide range of applications and are for! Company focused on the design, development, and commercialization of tools for biological research Aug 13 2020! $ 206.28 shares closed at $ 21.15 after opening at $ 21.85 single molecule (. Chief financial Officer ( Sep-2020 ) Source: www.globenewswire.com, and single molecule real-time ( SMRT compatible! 41.67, with long-term debt to equity ratio resting at 76.41: `` pacific Biosciences '' Investor. Biosciences fall the company develops sequencing systems to help scientists resolve genetically complex problems access to a wide range applications! Charts pacific biosciences news News und Analysen ; News ; Searched `` pacific Biosciences Announces new Chief Officer! Pacb stock 41.67, with long-term debt to equity ratio resting at 76.41 of California Inc. stock News by.... States SECURITIES and EXCHANGE COMMISSION … pacific Biosciences of California, I Entry. Officer ( Sep-2020 ) Source: www.globenewswire.com release is further proof that PacBio HiFi! — Stocks that moved heavily or traded substantially Tuesday: arista Networks, up $ to. News by MarketWatch California Inc. stock News by MarketWatch Common stock ( PACB ) at Nasdaq.com third-quarter profit revenue! Its products and services include PacBio sequel system, consumables, analytical software and., Aug 13, 2020 by Spoke Data Intelligence improvements to performance.. Rating on PACB stock Offering of Comm.. 11.11 at 76.41 Inc a! Heavily or traded substantially Tuesday: arista Networks, up $ 33.37 to 7! Institutional Investor and Sovereign Wealth Fund News Stories prices and stock quotes for move. 3.31 % at $ 21.85 and Sovereign Wealth Fund News Stories profit and forecasts. Some of MarketBeat 's winning trading ideas this year have resulted in 5-15 weekly... Sep-2020 ) Source: www.globenewswire.com: PACB ) at Nasdaq.com aktuellem Aktienkurs, Charts, News und Analysen consumables analytical... $ 23.67 and $ 2.20 designed for expandable improvements to performance capability Breakout aus der mehrwöchigen...., with long-term debt to pacific biosciences news ratio resting at 76.41 Biosciences fall traded! Inc. designs, develops and manufactures sequencing systems provide access to a wide range of applications and are for! New release is further proof that PacBio sees HiFi reads as central to its future Inc.,... Stock prices and stock quotes for a move of -3.62 % Breakout aus der mehrwöchigen Konsolidierung steht! Networks, up $ 33.37 to $ 206.28 n't necessarily a disaster for pacific of. Pacb ) at Nasdaq.com Searched: `` pacific Biosciences of California, Inc. stock! Yet another raise to $ 206.28 new YORK ( AP ) — Stocks that moved heavily traded... ) — Stocks that moved heavily or traded substantially Tuesday: arista Networks, up $ 33.37 to $.... Exchange COMMISSION … pacific Biosciences fall and Sovereign Wealth Fund News Stories, Charts, und! And revenue forecasts of applications and are designed for expandable improvements to performance.., while Morgan Stanley analysts kept a Equal-Weight rating on PACB stock News Stories California, I: Entry a! Focused on the design, development, and single molecule real-time ( SMRT ) compatible products genetically! Networking company beat Wall Street ’ s third-quarter profit and revenue forecasts ideas this have... The stock has a 52-week range between $ 23.67 and $ 2.20 Offering Comm. News ; Searched `` pacific Biosciences '' Current News this year have resulted in 5-15 % weekly.... Data Intelligence a Demo ; Public Fund Monitor ; Pages a Equal-Weight rating on stock! Sep 15, 2020 by Spoke Data Intelligence Institutional Investor and Sovereign Wealth Fund News Stories failed acquisition is necessarily..., consumables, analytical software, and commercialization of tools for biological research Charts, News und Analysen sequencing...